Obesity does not just enlarge fat stores, it appears to rework the body’s wiring and immune landscape in ways scientists have ...

Participants who were overweight or living with obesity wore the accessories for two hours every morning for six weeks and ...

A Cleveland Clinic study suggests GLP-1 weight loss drugs may help slow the spread of some obesity-related cancers.

GLP-1 medications were initially developed and prescribed to help manage blood sugar in people with Type 2 diabetes ...

New research suggests obesity may leave a long-lasting “memory” on the immune system, even years after weight loss.

Eli Lilly announced clinical trial results for retatrutide, its next gen obesity drug. The drug helped study participants lose 70 lbs over 80 weeks, making it more powerful than Zepbound and Wegovy.

Obesity is commonly diagnosed using BMI, but this approach has several limitations. Researchers at Lund University and ...

The MARITIME Phase 3 Chronic Weight Management Studies are Actively Enrolling, and Phase 3 Studies in People Living With Atherosclerotic Cardiovascular Disease, Heart Failure and Obstructive Sleep ...

Researchers say the findings of the study challenge the idea of a single global obesity “epidemic”, revealing major ...

A meta-analysis involving more than 43,000 adults with obesity, suggests that obesity medications, such as GLP-1 drugs, could ...

The study examined the relative importance of energy expenditure and calorie intake in relation to obesity Getty A new study examined the relative importance of energy expenditure and calorie intake ...